Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis

Osteoporosis is the most common osteolytic disease characterized by excessive osteoclast formation and resultant bone loss, which afflicts millions of patients around the world. Madecassoside (MA), isolated from Centella asiatica, was reported to have anti‐inflammatory and antioxidant activities, bu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cell Mol Med
Egile Nagusiak: Wang, Qingqing, Yao, Lingya, Xu, Ke, Jin, Haiming, Chen, Kai, Wang, Ziyi, Liu, Qian, Cao, Zhen, kenny, Jacob, Liu, Yuhao, Tickner, Jennifer, Xu, Huazi, Xu, Jiake
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307845/
https://ncbi.nlm.nih.gov/pubmed/30338925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13942
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak